Gland Pharma Share Price
(GLAND)
₹1519.95▲1.36%
as on 04:01PM, 20 Feb 2025
Gland Pharma Performance
Day's Low
Day's High
₹1,486.2Day's Price Range₹1,531.9552 Week's Low
52 Week's High
₹1,411.152-Week Price Range₹2,220.95
| Returns % | |
| 1 Month Return | -8.39 % |
| 3 Month Return | -14.94 % |
| 1 Year Return | -22.16 % |
| Market Stats | |
| Previous Close | ₹1,499.55 |
| Open | ₹1,501.15 |
| Volume | 1.16L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹25,041.44Cr |
Gland Pharma Key Statistics
P/E Ratio
35.55
PEG Ratio
12.88
Market Cap
₹25,041.44 Cr
P/B Ratio
3.37
EPS
46.9
Dividend Yield
1.09
Sector
Pharmaceuticals
ROE
12.31
Gland Pharma Mutual Fund Holdings
Gland Pharma Analyst Rating
based on 12 analysts
41.67%
Buy
8.33%
Hold
50.00%
Sell
Based on 12 analysts offering long term price targets for Gland Pharma. An average target of ₹1690.58
Source: S&P Global Market Intelligence
Gland Pharma Share analysis
Gland Pharma price forecast by 12 analysts
Upside of11.23%
High
₹3120
Target
₹1690.58
Low
₹1162
Gland Pharma target price ₹1690.58, a slight upside of 11.23% compared to current price of ₹1519.95. According to 12 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Gland Pharma revenue growth forecast
Expected growth rate Q1, FY2027:26.97%
Forecast
Actual
Including amortisation and stock based compensations
Gland Pharma EPS growth forecast
EPS estimate Q1, FY2027:49.72%
Forecast
Actual
Source: S&P Global Market Intelligence
Key events for Gland Pharma Ltd
Gland Pharma Target Price and Turnaround Potential - 19 Feb, 2025
Gland Pharma is under consideration for a turnaround due to potential corporate actions. Currently trading at Rs 1499.55, with a target price of Rs 1,654.Gland Pharma Attracts Major Private Equity Interest - 12 Feb, 2025
Global private equity firms Blackstone, Brookfield, and Warburg Pincus are in talks to acquire a majority stake in Gland Pharma, valued at nearly $3 billion. The company reported a revenue of ₹1,384 crore for the December quarter, with a profit after tax of ₹204.7 crore, indicating strong financial performance.Gland Pharma Target Price Adjusted to Rs 1840 - 05 Feb, 2025
Motilal Oswal recommends buying Gland Pharma with a target price of Rs 1840, citing better-than-expected margins despite challenges in Cenexi operations and a reduced earnings estimate.Gland Pharma Faces Revenue Decline and Share Drop - 04 Feb, 2025
Gland Pharma's Q3 results show a 7% PAT rise but a 10% revenue decline, leading to a 5% drop in shares. Analysts downgrade targets amid ongoing challenges with the Cenexi acquisition and weak US market performance.Gland Pharma Reports Mixed Q3 Results - 03 Feb, 2025
Gland Pharma's Q3 results show a 7% increase in net profit to ₹205 crore, despite a 10% decline in revenue to ₹1,384 crore. The company cites lower expenses mitigating production issues at its French unit, Cenexi, and emphasizes strategic partnerships for future growth.Gland Pharma Excluded from NSE F&O Segment - 24 Jan, 2025
Gland Pharma shares will be excluded from the NSE Futures & Options segment effective January 31, 2025. The stock has declined 27% from its peak.Gland Pharma Receives Neutral Upgrade Amid Target Price Cut - 21 Jan, 2025
Nomura upgraded Gland Pharma to 'Neutral' but reduced the target price to Rs 1,790 due to declining US exports. Despite this, improvements in product mix and Cenexi's performance are anticipated, with strong EBITDA margin expansion expected in the coming years.
Insights on Gland Pharma Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up
Foreign Institutions have increased holdings from 4.47% to 5.04% in Dec 2024 quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 8.32% to 8.33% in Dec 2024 quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, 143.76 Cr → 204.69 Cr (in ₹), with an average increase of 16.1% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 59.9% return, outperforming this stock by 83.6%
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 135.1% return, outperforming this stock by 189.0%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 51.83% of holdings in Dec 2024 quarter
NEGATIVE IMPACTPrice Dip
In the last 3 years, GLAND stock has moved down by -53.9%
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 1.46K Cr → 1.44K Cr (in ₹), with an average decrease of 1.6% per quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 32.83% to 32.37% in Dec 2024 quarter
Gland Pharma Financials
Index Inclusions
Gland Pharma Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 51.83% | 0.00 | |
| Foreign Institutions | 5.04% | 12.69 | |
| Mutual Funds | 32.37% | ||
| Retail Investors | 8.33% | 0.10 | |
| Others | 2.43% |
Gland Pharma Key Indicators
Gland Pharma Valuation
Gland Pharma in the last 5 years
Lowest (18.84x)
May 22, 2023
Today (35.55x)
February 20, 2025
Industry (51.76x)
February 20, 2025
Highest (67.14x)
August 12, 2021
Gland Pharma Earnings and Dividends
Gland Pharma Ltd Earnings Results
Gland Pharma Ltd’s net profit jumped 6.69% since last year same period to ₹204.69Cr in the Q3 2024-2025. On a quarterly growth basis, Gland Pharma Ltd has generated 25.17% jump in its net profits since last 3-months.
Read More about Earnings ResultsGland Pharma Ltd Dividends May,2024
In the quarter ending March 2024, Gland Pharma Ltd has declared dividend of ₹20 - translating a dividend yield of 1.32%.
Read More about Dividends
Gland Pharma Technicals Summary
Bearish
Neutral
Bullish
Gland Pharma Ltd is currently in a Bearish trading position according to technical analysis indicators.
Gland Pharma Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| HOLD | ₹25,041.44 Cr | -3.29% | 0.50 | ₹772 Cr | ₹5,664 Cr | |
| HOLD | ₹1,58,705.08 Cr | 35.34% | 0.50 | ₹1,600 Cr | ₹7,845 Cr | |
| BUY | ₹1,04,776.31 Cr | 37.04% | 0.67 | ₹1,656 Cr | ₹10,727 Cr | |
| BUY | ₹40,340.16 Cr | 1.38% | 0.58 | ₹1,297 Cr | ₹14,755 Cr | |
| BUY | ₹1,19,502.65 Cr | 48.8% | 0.50 | ₹4,155 Cr | ₹25,774 Cr |
About Gland Pharma
Gland Pharma's operations include the development, manufacture, and marketing of a wide range of injectable drugs and active pharmaceutical ingredients. The company's product portfolio includes antibiotics, anti-emetics, anti-diabetics, anti-epileptics, and other therapeutic categories. Its top products include cephalosporins, penicillins, and other injectable antibiotics.
Gland Pharma is well known for its popular brands, such as Cephalosporin, Penicillin, and Amikacin. These brands have been widely used in hospitals and clinics across India, as well as in other countries. In addition, the company has developed and launched a wide range of generic and branded injectables, including Cefazolin, Cefuroxime, and Amikacin.
Share Price: ₹1519.95 per share as on 20 Feb, 2025 04:01 PM
Market Capitalisation: ₹25,041.44Cr as of today
Revenue: ₹1,384.05Cr as on December 2024 (Q4 24)
Net Profit: ₹204.69Cr as on December 2024 (Q4 24)
Listing date: 20 Nov, 2020
Chairperson Name: Yiu Kwan Stanley Lau
| Organisation | Gland Pharma |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on Gland Pharma Ltd
What is Gland Pharma Ltd price today?
Gland Pharma Ltd share price today stands at ₹1519.95, Open: ₹1501.15, Previous Close: ₹1499.55, High: ₹1531.95, Low: ₹1486.2, 52 Week High: ₹2220.95, 52 Week Low: ₹1411.1.
How to Buy Gland Pharma Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Gland Pharma Ltd shares
Is Gland Pharma Ltd listed on NSE?
Gland Pharma Ltd is listed on NSE
Is Gland Pharma Ltd listed on BSE?
Gland Pharma Ltd is listed on BSE
What are today's High and Low prices of Gland Pharma Ltd?
- Today's highest price of Gland Pharma Ltd is ₹1531.95.
- Today's lowest price of Gland Pharma Ltd is ₹1486.2.
What are today's traded volumes of Gland Pharma Ltd?
Today's traded volume of Gland Pharma Ltd(GLAND) is 1.16L.
What is today's market capitalisation of Gland Pharma Ltd?
Today's market capitalisation of Gland Pharma Ltd(GLAND) is ₹25041.44Cr.
What is the 52 Week High and Low Range of Gland Pharma Ltd?
How much percentage Gland Pharma Ltd is down from its 52 Week High?
Gland Pharma Ltd (GLAND) share price is ₹1519.95. It is down -31.56% from its 52 Week High price of ₹2220.95
How much percentage Gland Pharma Ltd is up from its 52 Week low?
Gland Pharma Ltd (GLAND) share price is ₹1519.95. It is up 7.71% from its 52 Week Low price of ₹1411.1
What are the historical returns of Gland Pharma Ltd?
What is the PE ratio of Gland Pharma Ltd today?
PE Ratio of Gland Pharma Ltd is 35.55
PE ratio = Gland Pharma Ltd Market price per share / Gland Pharma Ltd Earnings per share